

HY-13024 · Free Sample (0.1 - 0.2 mg)
MedChemExpress · Cat: HY-13024
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/DCC-2036.html
Description
Rebastinib DCC-2036 is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.







